HK1219891A1 - 有機酸聚合物作為有效組分的、預防或抑制癌細胞生存的藥物 - Google Patents
有機酸聚合物作為有效組分的、預防或抑制癌細胞生存的藥物Info
- Publication number
- HK1219891A1 HK1219891A1 HK16107993.4A HK16107993A HK1219891A1 HK 1219891 A1 HK1219891 A1 HK 1219891A1 HK 16107993 A HK16107993 A HK 16107993A HK 1219891 A1 HK1219891 A1 HK 1219891A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- medicine
- preventing
- active ingredient
- cancer cells
- organic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013162872 | 2013-08-06 | ||
PCT/JP2014/070598 WO2015020040A1 (ja) | 2013-08-06 | 2014-08-05 | 有機酸重合体を有効成分とする癌細胞の生着予防又は生着抑制のための医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1219891A1 true HK1219891A1 (zh) | 2017-04-21 |
Family
ID=52461371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16107993.4A HK1219891A1 (zh) | 2013-08-06 | 2016-07-08 | 有機酸聚合物作為有效組分的、預防或抑制癌細胞生存的藥物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20160184347A1 (zh) |
EP (1) | EP3031462A4 (zh) |
JP (1) | JPWO2015020040A1 (zh) |
KR (1) | KR20160036564A (zh) |
CN (1) | CN105530945A (zh) |
AU (1) | AU2014303490A1 (zh) |
CA (1) | CA2920138A1 (zh) |
HK (1) | HK1219891A1 (zh) |
WO (1) | WO2015020040A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016104777A1 (ja) * | 2014-12-26 | 2016-06-30 | 国立大学法人九州大学 | がんの処置のための方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54115324A (en) | 1978-03-01 | 1979-09-07 | Sato Ryuichi | Organic germanium polymer |
US4271084A (en) * | 1978-03-01 | 1981-06-02 | Ryuichi Sato | Germanium-containing organic polymer and the process for the production of the same |
JPS55167222A (en) | 1979-06-16 | 1980-12-26 | Ryuichi Sato | Drug for warm-blooded animal comprising organogermanium polymer as main constituent |
JPS5916825A (ja) * | 1983-01-31 | 1984-01-28 | Ryuichi Sato | 有機ゲルマニウム重合体を主剤とする癌用薬剤 |
JPH02134318A (ja) | 1988-11-15 | 1990-05-23 | Sanwa Kagaku Kenkyusho Co Ltd | インターフェロン産生増強剤及び該増強剤を用いたインターフェロン産生増強組成物 |
US5240700A (en) * | 1989-12-29 | 1993-08-31 | Sanwa Kagaku Kenkyusho Co., Ltd. | Pharmaceutical composition comprising a medicament and 3-oxygermylpropionic acid |
US5560925A (en) * | 1993-11-09 | 1996-10-01 | Sanwa Kagaku Kenkyusho Co., Ltd. | Method of treating wart |
US5532272A (en) * | 1994-05-20 | 1996-07-02 | Sanwa Kagaku Kenkyusho Co., Ltd. | 3-oxygermylpropionic acid polymer, pharmaceutical composition containing same and method of preventing and/or curing symptoms of immune diseases using same |
JPH0859485A (ja) | 1994-08-26 | 1996-03-05 | Sanwa Kagaku Kenkyusho Co Ltd | 3ーオキシゲルミルプロピオン酸化合物を主成分とするメイラード反応阻害剤 |
JPH1149683A (ja) | 1997-08-08 | 1999-02-23 | Sanwa Kagaku Kenkyusho Co Ltd | 3−オキシゲルミルプロピオン酸8員性構造体を主成分とするインターロイキン10産生増強剤 |
JP4381495B2 (ja) * | 1998-10-30 | 2009-12-09 | 株式会社三和化学研究所 | 有機ゲルマニウム化合物を有効成分とするmcp−1受容体拮抗剤、及びmcp−1が関与する炎症性疾患及び臓器障害の発症予防または治療剤 |
JP2000229856A (ja) | 1999-02-08 | 2000-08-22 | Sanwa Kagaku Kenkyusho Co Ltd | 有機ゲルマニウム化合物を有効成分とする動脈硬化性疾患の発症予防又は治療剤 |
JP2003081843A (ja) | 2001-09-10 | 2003-03-19 | Sanwa Kagaku Kenkyusho Co Ltd | 有機ゲルマニウム化合物を有効成分とするii型糖尿病性腎症の発症予防又は治療剤。 |
UA87979C2 (ru) * | 2002-08-19 | 2009-09-10 | Астразенека Аб | Человеческое моноклональное антитело, которое нейтрализует моноцитарный хемоатрактантный белок (мср-1) |
EP1871798B1 (en) * | 2005-04-15 | 2009-10-14 | Rappaport Family Institute For Research in the Medical Sciences | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases |
EP2099454A4 (en) * | 2006-11-17 | 2010-11-10 | Abbott Lab | AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS |
JP4620169B1 (ja) | 2010-01-28 | 2011-01-26 | 株式会社三和化学研究所 | 有機酸重合体を有効成分とするクローン病の予防又は治療剤 |
-
2014
- 2014-08-05 EP EP14834780.0A patent/EP3031462A4/en not_active Withdrawn
- 2014-08-05 JP JP2015530899A patent/JPWO2015020040A1/ja active Pending
- 2014-08-05 CN CN201480044182.0A patent/CN105530945A/zh active Pending
- 2014-08-05 AU AU2014303490A patent/AU2014303490A1/en not_active Abandoned
- 2014-08-05 CA CA2920138A patent/CA2920138A1/en not_active Abandoned
- 2014-08-05 US US14/909,847 patent/US20160184347A1/en not_active Abandoned
- 2014-08-05 WO PCT/JP2014/070598 patent/WO2015020040A1/ja active Application Filing
- 2014-08-05 KR KR1020167002784A patent/KR20160036564A/ko not_active Application Discontinuation
-
2016
- 2016-07-08 HK HK16107993.4A patent/HK1219891A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015020040A1 (ja) | 2015-02-12 |
EP3031462A4 (en) | 2017-04-19 |
US20160184347A1 (en) | 2016-06-30 |
CA2920138A1 (en) | 2015-02-12 |
AU2014303490A1 (en) | 2016-03-17 |
KR20160036564A (ko) | 2016-04-04 |
CN105530945A (zh) | 2016-04-27 |
JPWO2015020040A1 (ja) | 2017-03-02 |
EP3031462A1 (en) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1209788A1 (zh) | 用於治療溶酶體貯積症的方法和組合物 | |
BR112015000437A2 (pt) | imunoconjugados, formulação farmacêutica, métodos de tratamento e de inbir a proliferação de uma célula | |
IL236221A (en) | History of theophyridone and pharmacological preparations containing them for the treatment of diseases | |
IL238713A0 (en) | Self-regulating active pharmaceutical ingredient release | |
HRP20180703T1 (hr) | Derivat 4-alkinil imidazola i lijek koji kao aktivni sastojak sadrži isti | |
HK1206623A1 (zh) | 藥物組合物和乳腺炎的治療 | |
ZA201405949B (en) | Pharmaceutical preparation containing and antivirally active dihydroquinazoline derivative | |
EP2825635A4 (en) | SYSTEMS AND SUBSTANCES FOR THE CRYOPRESERVATION OF VIABLE CELLS | |
EP2863984B8 (en) | Devices and systems for stimulation of tissues | |
EP3061452A4 (en) | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | |
EP2987786A4 (en) | AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE | |
IL236465A0 (en) | Pharmaceutical composition for delayed release of active substances | |
HK1217089A1 (zh) | 用於治療潰瘍性結腸炎含磷脂酰胆碱的藥物製劑 | |
PT2656843E (pt) | Ésteres de bendamustina e compostos relacionados e a sua utilização médica | |
HK1219891A1 (zh) | 有機酸聚合物作為有效組分的、預防或抑制癌細胞生存的藥物 | |
HK1203955A1 (zh) | 反式- -癸烯酸衍生物及含有其的藥物 | |
HK1206269A1 (zh) | 包含苯達莫司汀的藥物製劑 | |
ZA201508860B (en) | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid | |
AU2012903976A0 (en) | Skin Treatment Formulation |